Analystreport

Seelos Therapeutics, Inc. (NASDAQ: SEEL) had its price target lowered by analysts at Cantor Fitzgerald from $3.00 to $2.00.

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report